医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Fujifilm Completes Acquisition of Irvine Scientific Sales Company and IS Japan, Leading Companies of Cell Culture Media

2018年06月05日 PM06:31
このエントリーをはてなブックマークに追加


 

SANTA ANA, Calif.

FUJIFILM Corporation (President: Kenji Sukeno) announced today that it has completed the acquisition of Irvine Scientific Sales Company, Inc. (ISUS) and IS JAPAN CO.,LTD. (ISJ), leading companies in cell culture media for about US$800 million on June 1 in the United States.

To advance its growth strategies in the healthcare area, Fujifilm continues to invest in contract development and manufacturing of biopharmaceuticals and regenerative medicine. At FUJIFILM Diosynth Biotechnologies (FDB), manufacturing capacity for antibody drugs has been increased. FUJIFILM Cellular Dynamics (FCDI), a world-class developer and manufacturer of iPS cell technologies and know-how, is now a wholly owned subsidiary, and to enter the cell culture media business, Fujifilm acquired FUJIFILM Wako Pure Chemical, a leading reagent manufacturer.

With the acquisition of ISUS and ISJ, Fujifilm will now be able to provide a broad product portfolio from biopharmaceuticals to in vitro fertilization and cell therapy, strengthening its global business in addition to expanding domestic business through strong sales network in Japan. Utilizing its advanced chemical synthesis and design capabilities cultivated in the photographic film business and the cell preparation and culturing technologies of its group companies such as Japan Tissue Engineering, FCDI and FDB, Fujifilm will accelerate the development of highly competitive cell culture media, supporting the further growth of its cell culture media business. Further, by combining the Fujifilm Group’s bio-medical-related technologies and products with the cell culture media technologies and products of ISUS and ISJ, the company will expand the contact development and manufacturing business for biopharmaceuticals and reagent business, and also accelerate research and development in the area of regenerative medicine.

<Company Overview of ISUS and ISJ> (As of June 5, 2018)

    ISUS   ISJ
Company Name Irvine Scientific Sales Company, Inc. IS JAPAN CO.,LTD.
Location Santa Ana, California, U.S.A. Toda, Saitama, Japan
Year of incorporation 1970 1989
CEO Yutaka Yamaguchi Masatoshi Kato
Shareholder FUJIFILM Holdings America Corporation(100%) FUJIFILM(100%)

ENDS

For a high-resolution image please contact lorna.cuddon@zymecommunications.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20180605005803/en/

CONTACT

Irvine Scientific
Lori Serles
Phone: 949-261-7800 x145
Email:
lserles@irvinesci.com
or
Zyme
Communications

Lorna Cuddon
Phone: +44 (0)7811996942
Email:
lorna.cuddon@zymecommunications.com

同じカテゴリーの記事 

  • joimax® Obtains Registration for All Products in the Indian Market
  • Avistone Announces the Approval of Vebreltinib as the First MET-TKI Treatment for a Rare Brain Glioma Subtype in China
  • Inocras Pioneers Precision Health with Revolutionary Whole Genome Insights
  • エクセルゲン、バクスター・インターナショナルを提訴。口腔体温計の精度に関するデータの公表権を擁護
  • パース・バイオサイエンシズが研究室用自動化プロバイダー・プログラムをローンチし、ハミルトン、オープントロンズ、ラボワークス、SPTラボテックと提携